This week we highlight the challenges related to hepatitis B treatments and the U.S. Food and Drug Administration’s advisory committee meeting regarding timely accelerated approval confirmations. We also look at a new study that highlights COVID-19 rebounds and the exodus of life sciences researchers from ... READ MORE >
Health care
5 things to know in life sciences this week
This week we highlight the emergence of Denmark as a major life sciences hub in Europe and the impact of technology on patients, as well as awareness-building on clinical trials. We also look at growth of the life sciences industry in Utah and new legislation in Europe that some say will decrease ... READ MORE >
5 things to know in life sciences: Week of Oct. 30, 2023
This week, we highlight the potential U.S. ban on Apple Watches over patent infringement as well as an analysis of biopharma market cap as it relates to the new U.S. drug price negotiations. We also look at the White House's new artificial intelligence directive aimed to ensure ethical biotech ... READ MORE >
Reimagining rural health care with integrated networks
Most recently, 23 critical access hospitals in North Dakota created a clinically integrated network which intends to enhance primary care, referrals and chronic care management by participating in the Medicare Shared Savings Program. The network plans to invest in telehealth, quality improvement and IT ... READ MORE >
5 things to know in life sciences: Week of Oct. 23, 2023
This week, we highlight Minnesota’s designation as a medtech hub, new developments in medtech in the UK and increased licensing deals in the biopharma sector. Additionally, we spotlight a positive outlook for next year in the life sciences services sector. Lastly, we continue to look at the importance of ... READ MORE >
5 things to know in life sciences: Week of Oct. 16, 2023
This week we delve into the pharmaceutical industry’s reputation among neurology patient groups. Also, the biopharma industry continues to make substantial investments in mergers and acquisitions, and Korean contract development and manufacturing organizations struggle to meet the needs of the cell and ... READ MORE >
5 things to know in life sciences: Week of Oct. 9, 2023
This week, we delve into Bristol Myers Squibb's significant acquisition of Mirati Therapeutics. Also, we look at the U.S. Food and Drug Administration’s formation of a digital health advisory committee and the groundbreaking approval of a genetic test for cancer risk assessment. Additionally, we spotlight ... READ MORE >
Health care shows resiliency in jobs, but a shortage looms
The health care sector showcased its resiliency by contributing 41,000 jobs in September, according to the latest jobs report from the U.S. Bureau of Labor Statistics. While the increase is encouraging, the industry is facing a long-term shortage of 124,000 physicians by 2034, according to the ... READ MORE >
5 things to know in life sciences: Week of Oct. 2, 2023
This week we explore a significant financing for an artificial intelligence-based biotech company, an investment in medtech by the UK government and a U.S. Food and Drug Administration visit to a major medtech incubator. We also look at a new product using AI to provide information regarding clinical ... READ MORE >
5 things to know in life sciences: Week of Sept. 25, 2023
This week we explore the development of a drug to grow teeth and the start of clinical trials for rabies vaccines. We also look at the labor shortage in biopharma manufacturing and Medicare’s solvency concerns. In addition, we highlight a survey which shows that artificial intelligence is the top area for ... READ MORE >